Most patients with chronic lymphocytic leukemia eventually relapse. A bispecific antibody drug may give them "another can to ...

Developments in chronic lymphocytic leukemia (CLL) this year included the first CAR T-cell therapy approval for the chronic ...

Secondary immunodeficiency disease (SID) status was associated with significantly higher risk for severe bacterial infections ...

I haven’t been too happy with my blood work with CLL, but I try to enjoy what I can — including apples during fall.

"In this high-risk population with relapsed and refractory disease and extensive prior therapy, pirtobrutinib demonstrated ...

Panelists discuss how, coming into ASH 2024, the largest unmet needs in the treatment and management of chronic lymphocytic leukemia (CLL) and mantle cell lymphoma (MCL) include improving outcomes for ...

Rocker Mike Peters debuts the music video for his band The Alarm's song "Transition" as he searches for a donor amid a ...

Chronic lymphocytic leukemia (CLL) is a type of cancer that affects white blood cells (WBCs). Since these blood cells are part of the immune system, CLL affects the body’s ability to fight germs.

During a Case-Based Roundtable® event, Daniel A. Ermann, MD, discussed evaluation and treatment for a patient with relapsed ...

A combination of Imbruvica and venetoclax showed significantly prolonged progression-free survival in patients with untreated ...

A fixed duration combination of venetoclax with acalabrutinib, with or without obinutuzumab, was superior to standard ...

City of Hope®, one of the largest and most advanced cancer research and treatment organizations in the United States, whose ...